TCT-637 The transapical AccuFit bioprosthesis for transcatheter mitral valve replacement
نویسندگان
چکیده
منابع مشابه
Transcatheter transapical valve-in-valve implantation for degenerated mitral bioprosthesis
A 76-year-old woman with a history of aortic and mitral valve (Mosaic 19 mm; Hancock II 25 mm bioprosthesis, Medtronic Inc., Minneapolis, Minnesota) replacement and former coronary artery bypass grafting in 2010 (left internal mammary artery-left anterior descending artery (LIMA-LAD), aorta-obtuse marginal coronary artery (Ao-OM)) was admitted to our hospital with recurrent pulmonary edema. Her...
متن کاملTranscatheter Mitral Valve Replacement With a Novel Dual Stent Bioprosthesis.
There has been great interest in transcatheter mitral valve replacement (TMVR) as a potential therapy for high-risk patients with severe mitral regurgitation, with several distinct device systems undergoing first-in-man clinical studies. The Intrepid TMVR (Medtronic Inc, Redwood City, CA), designed for transapical delivery, comprises 2 interconnected self-expanding nitinol stents: (1) an inner ...
متن کاملTransapical mitral valve implant for the treatment of degenerated bioprosthesis.
Mailing Address: Rogério E. Sarmento-Leite • Av. Princesa Isabel, 370, Santana, Postal Code: 90620-000, Porto Alegre, RS – Brazil E-mail: [email protected], [email protected] Manuscript received May 04, 2012, revised manuscript September 05, 2012, accepted October 29, 2012.
متن کاملImprovement of Mitral Regurgitation after Transapical Transcatheter Aortic Valve Bioprosthesis Implantation
Background/Introduction Implantation of transcatheter aortic bioprosthesis has become a procedure with increasingly relevance in medical practice for the treatment of aortic stenosis, especially in patients with high or prohibitive surgical risk for traditional surgery. The presence of mitral regurgitation (MR) may be associated with increased morbidity and mortality, however, some studies have...
متن کاملTranscatheter and transapical aortic valve replacement.
Minimally invasive valve replacement is limited to bioprosthetic aortic and pulmonary valves for use in very specific populations of patients. Replacement via trans-catheter and transapical techniques should be used only in patients in whom traditional surgical replacement is deemed an unacceptable risk. Nursing management will focus heavily on care for comorbid conditions because of the high-r...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Journal of the American College of Cardiology
سال: 2016
ISSN: 0735-1097
DOI: 10.1016/j.jacc.2016.09.779